These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33939651)

  • 61. Unicentric mixed variant Castleman disease associated with Hashimoto disease: the role of PET/CT in staging and evaluating response to the treatment.
    Akosman C; Selcuk NA; Ordu C; Ercan S; Ekici ID; Oyan B
    Cancer Imaging; 2011 Jun; 11(1):52-5. PubMed ID: 21684830
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Unicentric Castleman disease, hyaline vascular variant, stromal rich, with increased plasma cells and a high level of serum IL-6: Raising the diagnostic and therapeutic issues.
    Lyapichev KA; Sukswai N; Strati P; Iyer SP; Medeiros LJ; Miranda RN
    Ann Diagn Pathol; 2019 Dec; 43():151398. PubMed ID: 31630065
    [No Abstract]   [Full Text] [Related]  

  • 63. Gastric Fundus Splenosis Mimicking Malignancy on FDG PET/CT.
    Guo L; Shen G
    Clin Nucl Med; 2024 Sep; 49(9):e439-e440. PubMed ID: 38598475
    [TBL] [Abstract][Full Text] [Related]  

  • 64. FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman's disease.
    Barker R; Kazmi F; Stebbing J; Ngan S; Chinn R; Nelson M; O'Doherty M; Bower M
    Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):648-52. PubMed ID: 19050873
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Role of 68 Ga-FAPI PET/CT in Screening Malignancy of Familial Adenomatous Polyposis.
    Erol Fenercioğlu Ö; Yarikkaya E; Beyhan E; Çermik TF; Ergül N
    Clin Nucl Med; 2023 Mar; 48(3):e141-e142. PubMed ID: 36240760
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differentiating renal pelvic cancer from renal cell carcinoma with 18-fluorodeoxyglucose positron emission tomography-computed tomography.
    Dursun M; Ozbek E; Otunctemur A; Besiroglu H
    J Cancer Res Ther; 2021; 17(4):901-905. PubMed ID: 34528539
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hepatic Involvement of IgG4-Related Disease Presenting as Multiple Hypermetabolic Masses on FDG PET/CT.
    Pan Q; Wang Y; Luo Y; Ma Y; Li F
    Clin Nucl Med; 2018 Oct; 43(10):777-779. PubMed ID: 30106859
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Case report of primary renal pelvis squamous cell carcinoma coexisting with long-standing calculi in left kidney on 18F-FDG PET/CT.
    Deng S; Zhang B; Huang Y; Li J; Sang S; Zhang W
    Medicine (Baltimore); 2017 Mar; 96(11):e6341. PubMed ID: 28296764
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Three Primary Carcinomas on 18F-FDG PET/CT: Intrahepatic Cholangiocarcinoma, Papillary Renal Cell Carcinoma, and Clear Cell Renal Cell Carcinoma.
    Wu D; Hu Y; Wei Q; Tian C; Bian Y
    Clin Nucl Med; 2018 Jun; 43(6):428-430. PubMed ID: 29561526
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Diffuse Skeletal Hemangiomatosis Mimicking Metastastic Disease on 18F-FDG PET/CT.
    Huang D; Ou X; Ye Y; Zhang W
    Clin Nucl Med; 2019 Mar; 44(3):e144-e147. PubMed ID: 30624273
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
    Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
    Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Early assessment with
    Tabei T; Nakaigawa N; Kaneta T; Ikeda I; Kondo K; Makiyama K; Hasumi H; Hayashi N; Kawahara T; Izumi K; Osaka K; Muraoka K; Teranishi JI; Miyoshi Y; Yumura Y; Uemura H; Kobayashi K; Inoue T; Yao M
    BMC Cancer; 2019 Apr; 19(1):298. PubMed ID: 30940117
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Renal Medullary Carcinoma on Dual-Time Point FDG PET/CT Imaging.
    Hou G; Jiang Y; Wang J; Li F; Cheng W
    Clin Nucl Med; 2020 Jun; 45(6):446-447. PubMed ID: 32332313
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Enhanced MRI and 18F-FDG PET/CT Findings of Preoperative Primary Renal Collecting Duct Carcinoma.
    Ge J; Zuo C; Guan Y; Liang Z
    Clin Nucl Med; 2016 Dec; 41(12):998-999. PubMed ID: 27775947
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Rapidly Progressing Renal Cell Cancer of the Left Native Kidney in a Renal Transplant Recipient With Unusual Sites of Metastasis Demonstrated in Serial 18F-FDG PET/CT.
    Rangan B K K; Ora M; Suraj AS; Parashar A; Gambhir S
    Clin Nucl Med; 2019 Oct; 44(10):e574-e576. PubMed ID: 31348078
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mixed Epithelial and Stromal Tumor of the Kidney Mimicking Malignancy on 18F-FDG PET/CT in a Patient With Breast Cancer.
    Li C; Tian Y; Shen M; Wen B; He Y
    Clin Nucl Med; 2018 Jul; 43(7):e239-e241. PubMed ID: 29659398
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Superiority of 68Ga-FAPI-04 in Delineation of Soft Tissue and Liver Metastases in Chromophobe Renal Cell Carcinoma for Restaging.
    Xie F; Fu L; Zhou W
    Clin Nucl Med; 2022 Dec; 47(12):e758-e759. PubMed ID: 36342807
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Post Contusion Breast Hematoma Mimicking Malignancy on FDG PET/CT.
    Levin D; Lantsberg S; Giladi MR; Kazap DE; Hod N
    Clin Nucl Med; 2020 Jul; 45(7):552-554. PubMed ID: 32404704
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Primary splenic epithelioid hemangioendothelioma with diffuse metastases revealed by FDG PET/CT imaging: A case report.
    Li X; Ma X; Hao J; Dong C; Wang Y
    Medicine (Baltimore); 2021 Apr; 100(13):e25065. PubMed ID: 33787588
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Eosinophilic Cystitis Mimicking Malignancy on FDG PET/CT.
    Guo L; Deng S; Shen G
    Clin Nucl Med; 2024 Apr; 49(4):e191-e192. PubMed ID: 38377365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.